New Drug Approvals Are the Wrong Metric for Cancer Policy
Pediatric News ,
How should we define success in cancer policy — what should the endpoint be? It’s debatable.
How should we define success in cancer policy — what should the endpoint be? It’s debatable.
How should we define success in cancer policy — what should the endpoint be? It's debatable.
Why should you be interested in global oncology? This was one of the questions a participant asked at the 2nd Royal Society of…